Medicamen Organics Complete Financial Statements
In FYNone, Medicamen Organics (MEDIORG) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -21.7% and ROE of -17.2%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore MEDIORG stock price history to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
MEDIORG Revenue, Net Profit & EBITDA — Year-on-Year Growth
MEDIORG YoY (March 2026 vs Period) — revenue -100.0%, net profit +100.0%, EBITDA +100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see MEDIORG share price.
MEDIORG Income Statement — Revenue, EBITDA & Net Profit
Medicamen Organics revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -21.7%. Analyse MEDIORG shareholding pattern to track promoter, FII and institutional holdings.
| Particulars | None | March 2026 | March 2025 | March 2024 |
|---|---|---|---|---|
| Revenue | 0 | 23 | 38 | 25 |
| Expenses | 0 | 26 | 32 | 21 |
| EBITDA | 0 | -4 | 7 | 5 |
| Operating Profit Margin % | 0.00% | -17.00% | 17.00% | 19.00% |
| Depreciation | 0 | 1 | 1 | 1 |
| Interest | 0 | 1 | 1 | 1 |
| Profit Before Tax | 0 | -5 | 5 | 4 |
| Tax | 0 | 0 | 1 | 2 |
| Net Profit | 0 | -5 | 4 | 3 |
| Earnings Per Share (₹) | 0.00 | -3.41 | 3.67 | 3.47 |
MEDIORG Balance Sheet — Assets, Liabilities & Shareholders' Equity
MEDIORG total assets ₹52 Cr, total equity ₹29 Cr, total liabilities ₹ Cr (2026) — ROE -17.2%.
| Particulars | 2026 | 2025 | 2024 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 52 | 59 | 38 |
| Current Assets | 37 | 45 | 27 |
| Fixed Assets | 14 | 10 | 10 |
| Capital Work in Progress | 0 | 2 | 0 |
| Investments | 11 | 0 | 0 |
| Other Assets | 0 | 47 | 28 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 1 | 2 | 2 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 29 | 31 | 15 |
| Share Capital | 12 | 12 | 9 |
| Reserves & Surplus | 17 | 18 | 7 |
MEDIORG Cash Flow Statement — Operating, Investing & Financing
Medicamen Organics operating cash flow ₹-5 Cr, investing ₹-2 Cr, financing ₹11 Cr, net cash flow ₹4 Cr (2025).
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | -5 | -4 |
| Investing Activities | -2 | 0 |
| Financing Activities | 11 | 4 |
| Net Cash Flow | 4 | 0 |